CYBIN INC. COMMON STOCK reports a Return on Equity (ROE) of -52.92%.

What is HELP's dividend yield?

CYBIN INC. COMMON STOCK offers a dividend yield of 0.00%.

What is HELP's Deepscope Quality Score?

Deepscope rates HELP's overall financial quality at 8 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy HELP?

Deepscope's AI Timing Score for HELP is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does HELP belong to?

CYBIN INC. COMMON STOCK is classified under the Healthcare >> Biotechnology sector on the NYSE MKT exchange.

HELP (NYSE MKT) Stock Analysis | CYBIN INC. COMMON STOCK

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-04 | FS: 2025-12-31)

HELP

CYBIN INC. COMMON STOCK

US:NYSE MKT STOCK Healthcare >> Biotechnology News 84

USD 4.43

0.13 (3.02%) Day Change

Watchlist Portfolio Compare Chart

0.06

D/E

-52.9%

ROE

-50.0%

ROA

0.00%

Div Yield

CYBIN INC. COMMON STOCK
TYPE: STOCK
MARKET: NYSE MKT

Compare Watchlist Myport

USD 4.43 Price 0.13 (3.02%) Day Change	NEWS SCORE: 84

HELP, the overall quality is not good ( Quality = 8) and the timing to buy is ...(Sign In to See)...

Loading chart...

8 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	84
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	4.43
PBV / Sector	0.78 / 4.58 GREAT
Earning Per Share	-2.99

PE / Sector	N/A / 17.10
PEG or PE/Growth / Sector	N/A / 0.52
Average 1M Daily Value	2.96 M GREAT
Average 1W Daily Value	2.54 M GREAT

Timing Factors

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 450.23
NPM Average (%) / Sector	N/A / -1,506.33
NPM Change Average (%) / Sector	N/A / 4,941.30
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-49.97 / 30.58
ROA Average (%) / Sector	-57.63 / -347.17
ROA Change Average (%) / Sector	5.58 / 5,125.52
ROE (%) / Sector	-52.92 / -3.58
ROE Average (%) / Sector	-62.93 / 40.65
ROE Change Average (%) / Sector	6.83 / 2,109.80
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.50
Dividend Change Average (%) / Sector	N/A / 5.02

Registration Details

Analyze Date	2026-06-05 09:12:26
Symbol	HELP
Name	CYBIN INC. COMMON STOCK
Sector	Healthcare >> Biotechnology
Market	NYSE MKT
Listed Shares	49.89 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	214.54 / 8,655.90

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 100 King Street West, Toronto, ON, Canada, M5X 1C9

Phone: 908-764-8385

Website: https://cybin.com

Sector: Healthcare >> Biotechnology

Description: Cybin Inc., doing business as Helus Pharma, a clinical-stage neuropsychiatry company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions. It develops CYB003, a deuterated psilocybin analog, which is in phase 3 clinical trial to treat major depressive disorder (MDD); and CYB004, a deuterated N, N-dimethyltryptamine (DMT), which is in phase 2 clinical trial for treating generalized anxiety disorders. The company also develops SPL028 injectable deuterated DMT completed phase 1 clinical intramuscular and intravenous trial; SPL026 for MDD; and CYB005, a phenethylamine derivative, which in preclinical stage to treat central nervous system, as well as has a research pipeline of investigational psychedelic-based compounds. It has a strategic partnership agreement with Segal Trials to support PARADIGM, a multinational pivotal phase 3 program evaluating CYB003 for the adjunctive treatment of major depressive disorder. The company is headquartered in Toronto, Canada.